Hamsters Protected from SARS-CoV-2 Delta Variant Challenge after Two Doses of Adjuvanted SARS-CoV-2 Recombinant Spike Protein (S-2P) and One Dose of Beta S-2P( )

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern negatively impact the effectiveness of vaccines. In this study, we challenge hamsters with the delta variant after 2- or 3-dose inoculations with SARS-CoV-2 vaccines constructed from stabilized prefusion spike proteins...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Tsun-Yung, Lien, Chia En, Lin, Yi-Jiun, Lin, Meei-Yun, Wu, Chung-Chin, Tang, Wei-Hsuan, Campbell, John D, Traquina, Paula, Chuang, Ya-Shan, Liu, Luke Tzu-Chi, Cheng, Jinyi, Chen, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047188/
https://www.ncbi.nlm.nih.gov/pubmed/35451470
http://dx.doi.org/10.1093/infdis/jiac153

Ejemplares similares

Ejemplares similares